首页> 美国政府科技报告 >Ablation or Reduction of Intraoperative Tourniquet Pain with PreoperativeAdministration of IV Ketorolac Tromethamine
【24h】

Ablation or Reduction of Intraoperative Tourniquet Pain with PreoperativeAdministration of IV Ketorolac Tromethamine

机译:术前静脉注射IV酮咯酸氨丁三醇可消除或减少术中止血痛

获取原文

摘要

The application of tourniquets on upper or lower extremities is frequently usedby surgeons to provide a clear operative field while minimizing blood loss. These are attractive benefits for utilization of tourniquets, however consequences do exist. The release of prostaglandins by injured cells in response to tourniquet compression increases pain perception. This occurs by prostaglandins sensitizing and exciting pain receptors. The purpose of this research is to determine the efficacy of a preoperative dose of ketorolac tromethamine, given prior to tourniquet inflation for orthopedic surgery, to maintain baseline heart rate and blood pressure values. Ketorolac tromethamine, a nonsteroidal antiinflammatory drug, has physiologic action based upon prostaglandin reduction. It acts peripherally by inhibiting the enzyme cyclooxygenase which converts arachidonic acid to prostaglandins (Stoelting, 1991).

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号